SH-5 

SH-5 is a potent AKT inhibitor. SH-5 potentiates the apoptosis induced by tumor necrosis factor. SH-5 blocks NF-kB activation induced by TNF-a, lipopolysaccharide (HY-D1056), phorbol ester (HY-18739), and cigarette smoke^[1].

SH-5 (5 µM; 4+24 h) increases the cytotoxicity with 1 nM TNF in H1299 cells^[1].
SH-5 (5 µM; 4+0, 6, 12, 18, 24 h) potentiates the apoptosis induced by tumor necrosis factor (TNF) in H1299 cells^[1].
SH-5 (1, 3, 5 µM) inhibits TNF (1 nM; 24 h)-induced COX-2 gene expression in a dose-dependent manner^[1]. SH-5 (5 µM; 4+0, 6, 12, 18, 24 h) decreases the protein expression of 1 nM TNF-induced IAP-1, XIAP, Bcl-Xl, Bcl-2, TRAF1, Survivin, COX-2, Cyclin D1, MMP-9 in a time-dependent manner in KBM-5 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

598.75

C₂₉H₅₉O₁₀P

701976-54-7

CCCCCCCCCCCCCCCCCCOC[C@@H](OC)COP(O[C@@H]1[C@@H](C[C@H]([C@@H]([C@H]1O)O)O)OC)(O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Sethi G, et al. SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation. Biochem Pharmacol. 2008 Dec 1;76(11):1404-16.  [Content Brief]